Intensity Therapeutics Inc (INTS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intensity Therapeutics Inc   (NASDAQ: INTS)


Intensity Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Intensity Therapeutics Inc's ROI in the second quarter of 2026?
Intensity Therapeutics Inc recorded a cumulative net loss of $-11 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -115.71%.

Within the Healthcare sector 637 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4028 to 4144.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 350.7 % 168.82 % 3.65 % -26.5 % -72.25 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 9 10 12 7 2
Return On Investment (TTM) -115.71 % -135.39 % -211.22 % -361.8 % -587.62 %
INTS's Overall Ranking # 4144 # 4028 # 3688 # 3795 # 2927
Seq. Investment Change TTM 22.15 % 43.74 % 69.39 % 51.54 % -27.14 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -11 -11 -12 -12 -13

INTS Company Profile >> Back to INTS Roi Comparisons >> See Annual INTS Return On Investment



Return On Investment INTS's Ranking
Within: No.
Industry # 110
Sector # 638
Overall # 4144

Return On Investment Statistics
High Average Low
-97.58 %
-289.1 %
-587.62 %
(Jun 30 2023)   (Jun 30 2025)







Financial Statements
Intensity Therapeutics Inc's II. Quarter Investments $ 9 Millions INTS's Balance sheet
Intensity Therapeutics Inc's II. Quarter Income $ -3 Millions Quarterly INTS's Income Statement
INTS's Income by Division See INTS's Income by Division


INTS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2022)
2023

Total Investments in Millions 12 3 -1 0 0
Y / Y Investment Growth 305.12 % - - - -
Net Income in Millions -12 -16 -8 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -97.08 % -551.27 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INTS's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INTS's Competitors
Subscribers only: Roi for Intensity Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for INTS's Customers

Other Ratios
INTS's Roa INTS's Inventory Turnover Ratio INTS's Growth Rates INTS's Dividend Statistics
INTS's Profitability Ratios INTS's Asset Turnover Ratio INTS's Dividend Growth
INTS's Roe INTS's Valuation Ratios INTS's Financial Strength Ratios INTS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:42:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.